Stockscreener 앱 받기
2.71
2.52%
-0.07
시장 영업 전:
2.73
0.02
+0.74%
전일 마감가:
$2.78
열려 있는:
$2.78
하루 거래량:
38,084
Relative Volume:
0.10
시가총액:
$28.87M
수익:
-
순이익/손실:
-
주가수익비율:
-3.3598
EPS:
-0.8066
순현금흐름:
-
1주 성능:
+1.50%
1개월 성능:
+6.69%
6개월 성능:
+0.74%
1년 성능:
-11.73%
1일 변동 폭
$2.71
$2.82
1주일 범위
$2.645
$2.8299
52주 변동 폭
$1.33
$6.20
Neuraxis Inc Stock (NRXS) Company Profile
명칭
Neuraxis Inc
전화
(812) 689-0791
주소
11550 North Meridian Street, Suite 325, Carmel
NRXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
2.71 | 29.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neuraxis Inc 주식(NRXS)의 최신 뉴스
Is Neuraxis Inc. stock a defensive play amid uncertaintyJuly 2025 Gainers & Technical Entry and Exit Tips - Newser
Is Neuraxis Inc. stock good for wealth creationQuarterly Profit Review & Low Drawdown Investment Ideas - Newser
How supply shortages influence Neuraxis Inc. stock2025 Support & Resistance & High Yield Stock Recommendations - Newser
Is Neuraxis Inc. stock undervalued after correctionJuly 2025 Gainers & Safe Entry Trade Signal Reports - Newser
Neuraxis secures VA Federal Supply Schedule contract - MSN
What dividend safety rating applies to Neuraxis Inc. stockJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Neuraxis secures veterans affairs federal supply schedule contract, broadening access to more patients with functional abdominal pain - MarketScreener
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain - The Manila Times
NeurAxis (NYSE American: NRXS) lands VA FSS deal, opening path to nearly 7M veterans - Stock Titan
NeurAxis, Inc. (NRXS) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How NeurAxis Inc. stock reacts to global recession fearsBond Market & Community Verified Trade Signals - moha.gov.vn
Can NeurAxis Inc. stock double in next 5 yearsJuly 2025 Summary & Trade Opportunity Analysis - BỘ NỘI VỤ
NeurAxis Expands Stock Offering to $6.27 Million - MSN
What analysts say about NeurAxis Inc stockMACD Trading Signals & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Why Neuraxis Inc. stock is trending on social mediaSwing Trade & Safe Entry Point Alerts - newser.com
Published on: 2025-11-20 05:27:18 - newser.com
Is NeurAxis Inc. stock attractive for long term wealth buildingTrade Analysis Report & Verified Stock Trade Ideas - newser.com
Can NeurAxis Inc. stock hit analyst price targetsEarnings Risk Report & Community Verified Trade Alerts - newser.com
Using Ichimoku Cloud for NeurAxis Inc. technicals2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth - MSN
Why Neuraxis Inc. stock is favored by hedge funds2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com
Will NeurAxis Inc. continue its uptrendWeekly Volume Report & Safe Entry Point Alerts - newser.com
Using data models to predict NeurAxis Inc. stock movementEarnings Risk Summary & Real-Time Chart Breakout Alerts - newser.com
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2024 Earnings Call Transcript - MSN
Risk vs reward if holding onto NeurAxis Inc.Earnings Performance Report & Stepwise Entry and Exit Trade Signals - newser.com
What to do if you’re stuck in NeurAxis Inc.July 2025 Breakouts & Real-Time Market Trend Scan - newser.com
NeurAxis, Inc. Earnings Call: Growth Amid Challenges - MSN
Neuraxis announces new medical policy coverage in Michigan - MSN
Can Neuraxis Inc. stock hold up in economic slowdown2025 Market Trends & High Accuracy Swing Entry Alerts - newser.com
Neuraxis Inc (NRXS) 재무 분석
Neuraxis Inc (NRXS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):